These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 27144602)

  • 21. In defense of life sciences venture investing.
    Booth BL; Salehizadeh B
    Nat Biotechnol; 2011 Jul; 29(7):579-83. PubMed ID: 21747380
    [No Abstract]   [Full Text] [Related]  

  • 22. Survey reveals US university licensing up, startup formation down.
    Bouchie A
    Nat Biotechnol; 2005 Feb; 23(2):261-2. PubMed ID: 15724274
    [No Abstract]   [Full Text] [Related]  

  • 23. Who took the tech out of biotech?
    Silverman E
    Nat Biotechnol; 2006 Mar; 24(3):255-6. PubMed ID: 16525373
    [No Abstract]   [Full Text] [Related]  

  • 24. Biologist aims to ease the pain for entrepreneurs.
    Gewin V
    Nature; 2006 Apr; 440(7085):738-9. PubMed ID: 16598227
    [No Abstract]   [Full Text] [Related]  

  • 25. Embrace failure to start up success.
    Blank S
    Nature; 2011 Sep; 477(7363):133. PubMed ID: 21900972
    [No Abstract]   [Full Text] [Related]  

  • 26. Start-up model patently flawed.
    Corbyn Z
    Nature; 2010 Jul; 466(7304):303. PubMed ID: 20631768
    [No Abstract]   [Full Text] [Related]  

  • 27. US venture capital for biotechnology.
    Dibner MD; Trull M; Howell M
    Nat Biotechnol; 2003 Jun; 21(6):613-7. PubMed ID: 12776144
    [No Abstract]   [Full Text] [Related]  

  • 28. Dusting off outdated patterns.
    Munroe I
    Nature; 2017 Mar; 543(7646):S23-S26. PubMed ID: 28328911
    [No Abstract]   [Full Text] [Related]  

  • 29. Start-ups: In search of venture capital.
    Kellogg S
    Nature; 2011 Apr; 472(7343):379-80. PubMed ID: 21656939
    [No Abstract]   [Full Text] [Related]  

  • 30. Biotech's wellspring: the health of private biotech in 2012.
    Huggett B
    Nat Biotechnol; 2013 May; 31(5):396-403. PubMed ID: 23657390
    [No Abstract]   [Full Text] [Related]  

  • 31. Stelios Papadopoulos.
    Papadopoulos S
    Nat Biotechnol; 2011 Mar; 29(3):184. PubMed ID: 21390003
    [No Abstract]   [Full Text] [Related]  

  • 32. Lessons from Bayh-Dole.
    Sampat BN
    Nature; 2010 Dec; 468(7325):755-6. PubMed ID: 21150971
    [No Abstract]   [Full Text] [Related]  

  • 33. The rise of the European bioentrepreneur.
    Alper J
    Nat Biotechnol; 2002 Jul; 20 Suppl():BE3-5. PubMed ID: 12089569
    [No Abstract]   [Full Text] [Related]  

  • 34. Mixed results in Q1.
    Lawrence S
    Nat Biotechnol; 2005 May; 23(5):518. PubMed ID: 15877059
    [No Abstract]   [Full Text] [Related]  

  • 35. Realizing potential: the state of Asian bioentrepreneurship.
    Tang CM; Mahmud MA; Foo FK; Chu SY; Chiu RI; Tanticharoen M; Zhang L; Chang TW
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE15-22. PubMed ID: 12874972
    [No Abstract]   [Full Text] [Related]  

  • 36. CRISPR: Pursuit of profit poisons collaboration.
    Sherkow JS
    Nature; 2016 Apr; 532(7598):172-3. PubMed ID: 27075081
    [No Abstract]   [Full Text] [Related]  

  • 37. More for the research dollar.
    Furman JL; Murray F; Stern S
    Nature; 2010 Dec; 468(7325):757-8. PubMed ID: 21150972
    [No Abstract]   [Full Text] [Related]  

  • 38. How Indian biotech is driving innovation.
    Nogrady B
    Nature; 2018 Dec; 564(7735):S53-S55. PubMed ID: 30542184
    [No Abstract]   [Full Text] [Related]  

  • 39. Biotech parks proliferate, despite concerns over sustainability.
    Jia H; Jayaraman KS; Orellana C
    Nat Biotechnol; 2003 Nov; 21(11):1259-60. PubMed ID: 14595344
    [No Abstract]   [Full Text] [Related]  

  • 40. A patent problem.
    Nature; 2015 May; 521(7552):159-60. PubMed ID: 25993919
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.